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I. INTRODUCTIONIN April 2011, an Army Sergeant and medic shot and killed his wife
and then took his own life while under the influence of "bath salts."'
The couple's five-year-old son was later found suffocated to death in
their Washington home. 2 Similarly, while paralyzed for hours after smok-
ing synthetic marijuana with her friends and unable to move, a Kentucky
teen could sense her friends frantically trying to rouse her, and she even
* J.D. Candidate 2014, SMU Dedman School of Law; B.A. Technical Writing 2009,
University of North Texas. The author would like to thank her family and friends for their
continued support and for always encouraging her love of writing.
1. Christine Clarridge, Fort Lewis Soldier Who Killed Wife, Self Had Taken Synthetic





overheard them contemplate throwing her body in a nearby river.3 In
Waco, Texas, a twenty-two year old man tortured, killed, and ate his
roommate's dog-all while high on "Spice." 4
Although these horrific and life-altering events occurred on different
dates and in different parts of the United States, they were all instigated
by the use of synthetic drugs, specifically synthetic marijuana (commonly
known as "K2" or "Spice") and bath salts, a drug intended to mimic the
effects of methamphetamines.5 Until recently, many of these drugs were
legally obtainable and widely available; however, state and federal legis-
lators have scrambled to ban the ingredients in these drugs to keep them
off the shelves of local convenience stores and smoke shops.6 But wide-
spread bans have prompted synthetic drug manufacturers and chemists to
quickly formulate new variations to circumvent current prohibitions.7
Thus, synthetic drug manufacturers and legislators are involved in a circu-
lar struggle, wherein the drug manufacturers are persistently synthesizing
unknown chemical variants to dodge illegalities, and, in response,
lawmakers and government agencies are trying to stop the synthetic drug
movement by implementing more bans to target these newly fabricated
substances.8 In addition, extensive bans and crackdowns have resulted in
a surge of criminal charges for synthetic drug consumers, retailers, and
manufacturers. 9 The ongoing issues surrounding synthetic drugs have not
only sparked a national media frenzy, but have also destroyed and endan-
gered thousands of lives because the side effects of these drugs are not
yet fully understood and still pose a mystery to healthcare providers,
paramedics, and law enforcement agents.10
This Comment explores the emergence of synthetic marijuana and bath
salts in the United States and focuses on the consequences that these
newly created drugs have had on state and federal legislation, law en-
forcement, and criminal law. Part II of this Comment outlines the origins,
emergence, and effects of both synthetic marijuana and bath salts-the
3. See Kristen Snyder, Drug Was Fake; Fear Was Real, MADISON COURIER (Feb. 18,
2012, 8:58 AM), http://madisoncourier.com/main.asp?SectionlD=178&SubSectionlD=961
&ArticlelD=67926.
4. See Randy Kreider, Man Bites Dog, Eats Dog While High on 'Spice', ABC NEWS
(June 27, 2012), http://abcnews.go.com/Blotter/man-bites-dog-eats-dog-high-spice/story?id
=16660512.
5. See Rommie L. Duckworth, Bath Salts and Synthetic Marijuana: An Emerging
Threat, FIRE ENGINEERING, Nov. 2012, at 33.
6. See OFFICE OF NAT'L DRUG CONTROL POLICY, FACT SHEET: SYNTHETIC DRUGS
(2012) [hereinafter WHITE HOUSE FACr SHEET], available at http://www.whitehouse.gov/
sites/default/files/pagefiles/syntheticdrugsfact sheet_455_215-12.pdf.
7. See id.
8. See Alison Knopf, Federal Officials Concerned about 'Bath Salts' and Related De-
signer Drugs, ALCOHOLISM & DRUG ABUSE WKLY. (Feb. 7, 2011), http://www.alcoholism
drugabuseweekly.com/sample-articles/federal-officials-concerned-bath-salts-designer-
drugs.aspx.
9. See News Release, DEA, Nationwide Synthetic Drug Takedown (July 26, 2012),
available at http://www.justice.gov/dealpubs/pressrel/pr072612.html [hereinafter DEA
News Release 1].
10. See Duckworth, supra note 5, at 32.
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two designer drugs primarily responsible for widespread state and federal
bans and legislation." Part III provides an overview of recent federal reg-
ulatory and legislative actions implemented to suppress and counteract
the proliferation of these drugs. Part III also exposes the consequential
legal liability and criminal repercussions brought about by newly enacted
state and federal prohibitions and discusses recent and currently develop-
ing case law involving synthetic marijuana and bath salt products. Finally,
Part IV evaluates these sweeping regulatory implementations in light of
their criminal and legal aftermath, and also exposes the drawbacks and
shortcomings of overly ambitious state and federal endeavors to control
and eradicate designer drugs.
II. TRACING THE ORIGINS OF DESIGNER DRUGS:
SYNTHETIC MARIJUANA AND BATH SALTS
Relying on mere technicalities to skirt regulatory drug laws is not a
new concept.12 In fact, this process first appeared around the 1920s when
drug manufacturers opted to sell a chemically similar variation of mor-
phine to avoid penalties under the International Opium Convention of
1925.13 Synthetic drugs are often called "designer drugs" because they do
not exist naturally, unlike tetrahydrocannabinol ("THC"), the active
compound in the Cannabis (marijuana) plant. 14 By contrast, designer
drugs are purposely created when "underground 'chemists'[ ] slightly al-
ter-or design-molecules of existing banned drugs to evade the law and
sell abusable drugs."' 5 These manmade variations are referred to as ana-
logues, and although inspired by the molecular structure of preexisting
recreational drugs and controlled substances, they have an "ever-chang-
ing ingredient list," which makes them dangerous to ingest and difficult to
track and regulate.16 Also, many designer drugs sold today are disguised
as household products and carry a label that reads "not for human con-
sumption"-a clever detail that complicates an already novel and quickly
evolving concept by creating confusion about whether these substances
should be identified as legal products or as psychoactive drugs that should
be regulated, banned, or criminalized. 7 To truly capture the far-reaching
social and legal impact of synthetic drugs, it is important to understand
their origins, side effects, and the process of their manufacture and sale.
11. See WHiTE HOUSE FACT SHEET, supra note 6; see also News Release, DEA, Con-
gress Agrees to Add 26 Synthetic Drugs to Controlled Substances Act (June 19, 2012)
[hereinafter DEA News Release 2], available at http://www.justice.gov/dea/pubs/pressrel/
pr061912.html.
12. See Duckworth, supra note 5, at 32.
13. Id.
14. See id.
15. Knopf, supra note 8.
16. See Duckworth, supra note 5, at 32.




Marijuana analogues were initially the outcome of scientific and phar-
maceutical research in the 1960s aimed at manipulating THC molecules
to separate marijuana's negative effects from its medically beneficial
uses.18 However, the sale and recreational use of synthetic marijuana was
first noticed in November 2008, when U.S. Customs and Border Protec-
tion encountered suspicious substances that were identified as "synthetic
cannabinoids" by the Drug Enforcement Administration's ("DEA") fo-
rensic department. 19 These synthetic concoctions were not created for the
purpose of scientific study or medical research; rather, they were de-
signed and mass-produced for commercial sale and were branded with
names like "K2" and "Spice," which are currently the most common
street names for synthetic marijuana products. 20
Synthetic marijuana is often marketed and advertised as herbal in-
cense, and consists of loose herbs or dried leaves that resemble cooking
spices or potpourri. 21 It is typically packaged in small, square-shaped
plastic bags and sold in "head shops" (stores that sell products pertaining
to smoking and recreational drug use), tobacco stores, internet websites,
and even gas stations and convenience stores. 22 Despite their simple and
unassuming exterior, these neatly packaged incense products are actually
"a mixture of herbs and spices . . . sprayed with a synthetic compound
chemically similar to THC, the psychoactive ingredients in marijuana." 23
Although there are over 100 types of synthetic cannabinoids, many of
which are currently banned either federally or locally, Spice products
commonly consist of JWH-018 (the most popular synthetic cannabinoid
formulation), 24 JWH-073, HU-210, or HU-211. 25
Much like users of actual marijuana, users of Spice often smoke the
product in a pipe or use rolling papers to make joints or cigarettes. 26
Spice users hope to achieve the same effects brought about by marijuana,
such as "euphoria, relaxation, and sociability," yet the unfortunate reality
is that these drugs have induced a laundry list of harmful reactions be-
cause they are not regulated, have no quality control, and are often sup-
18. See Duckworth, supra note 5, at 34.
19. WHITE HOUSE FACr SHEET, supra nOte 6.
20. See id.
21. See DEA, DRUG FACT SHEET: K2 OR SPICE (2011) [hereinafter K2 FACT SHEET],
available at http://www.justice.gov/dealdruginfo/drug-data-sheets/K2_Spice.pdf.
22. See id.; see also Dan Quan, Legal Drugs ofAbuse, 32 EMERGENCY MED. REP. 237,
239 (2011).
23. See K2 FACT SHEET, supra note 21.
24. See Duckworth, supra note 5, at 35. JWH-018 and JWH-073 are now Schedule I
drugs. See Synthetic Drug Abuse Prevention Act of 2012, Pub. L. No. 112-144, § 1152, 126
Stat. 993, 1131. HU-210 and HU-211 analogues have been banned in several states. See
Synthetic Cannabinoids (a.k.a. "KC"/ "Spice" Enactments, NATIONAL CONFERENCE OF
STATE LEGISLATURES (Nov. 28, 2012), http://www.ncsl.org/issues-research/justice/synthet
ic-cannabinoids-enactments.aspx (citing a complete list of state synthetic cannabinoid
bans).




plemented with random filler ingredients.27 The reported physical,
neurological, and psychological side effects are a serious cause for con-
cern: "tachycardia, hypertension, and chest pain or myocardial infarc-
tion . . . parasthesias, anxiety, psychosis, paranoia, confusion, tremors,
seizures, hallucinations, and excited delirium . . . suicidal ideation, self-
mutilation, and highly aggressive behavior."28 The effects of synthetic
marijuana can last between one and six hours and vary from person to
person, with some users reporting a positive or even unremarkable reac-
tion, whereas others end up in the emergency room with complaints of
panic, body aches, and racing heartbeats.29 Also, like many controlled
substances, Spice can be addictive or habit-forming, and because the
trend of recreational synthetic marijuana use is relatively new, the re-
search relaying its side effects is not yet exhaustive, and there is no guide
about what constitutes safe or tolerable dosages.30
Another major issue involves the marketing tactics of synthetic drug
manufacturers, who capitalize on the idea that the drug is a legal alterna-
tive to natural marijuana.3' Thus, Spice has become extremely popular
amongst teenagers and young adults who can now easily satisfy their de-
sire to experiment with recreational drugs by purchasing an over-the-
counter product at a local head shop or convenience store.32 The Office
of National Drug Control Policy reports that in a 2011 synthetic drug
study "11.4 percent of 12th graders used Spice or K2 in the past year,
making it the second most commonly used illicit drug among [high
school] seniors."33 Furthermore, the American Association of Poison
Control Centers reported that "2,906 calls relating to human exposure to
synthetic marijuana were received in 2010. Twice that number (6,959)
were received in 2011, and 639 had been received as of January 2012."34
Moreover, many uninformed and impressionable youths equate the
drug's technically legal status and widespread availability with the notion
that the drug is a milder, less dangerous version of marijuana.35 Synthetic
marijuana also largely appeals to many of its users because it often goes
undetected in routine drug tests or urinalyses required by employers
since basic drug tests merely detect traces of actual THC, but not syn-
thetic cannabinoids. 36 Despite its convenience or perceived legality, syn-
thetic marijuana is a dangerous substance that has contributed to several
deaths and injuries across the United States.37
27. See Duckworth, supra note 5, at 35.
28. Id.
29. See id. at 35-36.
30. See id. at 35.




35. See Joel Rose, Fake Pot is a Real Problem for Regulators, NPR (July 12, 2012, 3:04
AM), http://www.npr.org/2012/07/12/156615024/fake-pot-is-a-real-problem-for-regulators.
36. See id.
37. See id. (reporting that synthetic marijuana has been the culprit of "hundreds of




In many aspects, bath salts mirror the origins, prevalence, and manu-
facturing methods of synthetic marijuana because both are designer drugs
intended to produce "'legal' highs" without the interference of legislative
or regulatory control.38 One major difference is that synthetic marijuana
is considered by its users to be "'fake weed,"' whereas bath salts are
known as legal ecstasy (MDMA) or cocaine. 39 Although the growing
prevalence of synthetic marijuana generated feelings of caution, curiosity,
and concern, the emergence of bath salts amplified this sentiment into a
public uproar that fully captured the attention of the media, state and
federal legislators, and the entire nation.40 Bath salts became a media
sensation due to a gruesome and highly publicized crime that occurred in
Miami, Florida, on May 26, 2012, involving a "[b]ible-toting 31-year-old"
man named Rudy Eugene.41 Eugene, who was presumed to be under the
influence of bath salts, shed all of his clothing and not only ruthlessly
attacked a homeless man, but also began tearing away parts of the man's
face and eating his flesh.42 A stunned police officer encountered the can-
nibalistic scene and fatally shot Eugene after ordering him to stop, but
Eugene simply growled at the officer and continued his attack. 43 Toxicol-
ogy reports later confirmed that Eugene had no traces of bath salts in his
system (only traces of natural marijuana) at the time of the crime, but the
news of zombie attacks resulting in violence and cannibalism solidified
the idea that synthetic drugs are not merely innocent concoctions-they
are serious chemicals that pose a substantial threat to their users and the
general public. 44
In the world of designer drugs, bath salts have no relation to the thera-
peutic products sold in health stores or beauty and spa salons.45 Rather,
"bath salts" is a street name for a designer drug that emerged in the
old man who died from "'acute intoxication"' brought about by Spice and alcohol con-
sumption); see also Quan, supra note 22 (noting that "an Iowa teenager with no past medi-
cal history of depression or other psychiatric illness committed suicide while intoxicated
with K2").
38. See WHITE HOUSE FACT SHEET, supra note 6.
39. Compare K2 FACT SHEET, supra note 21, with DEA, DRUG FACT SHEET: BATH
SALTS OR DESIGNER CATHINONES (2011) [hereinafter BATH SALTS FACT SHEET], available
at http://www.justice.gov/dea/druginfo/drug-data-sheets/Bath-Salts.pdf (noting that the
DEA reports that both drugs are advertised with similar purposes and are sold in the same
retail markets).
40. See Bath Salts: The Synthetic Scare, ECONOMIST (Aug. 4, 2012), http://www.econo
mist.com/node/21559978; Jacob Sullum, Bath Salts Face Off, REASON (Oct. 2012), http://rea
son.com/archives/2012/08/22/bath-salts-face-off.
41. See Sullum, supra note 40.
42. Rudy Eugene: No Bath Salts, Only Marijuana Found in Face-Eater Toxicology
Tests, HUFFINGTON POST MIAMI (June 27, 2012), http://www.huffingtonpost.com/2012/06/
27/rudy-eugene-face-marijuana-medical-examiner-results-n_1632253.html.
43. See id.
44. See id.; Celia Vimont, Using Bath Salts: Playing Russian Roulette with Your Brain,
Expert Says, DRUGFREE.ORG (Jan. 15, 2013), http://www.drugfree.org/join-together/drugs/
using-bath-salts-playing-russian-roulette-with-your-brain-expert-says.
45. See Quan, supra note 22, at 241.
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United States in 2008 that is often composed of "analog[ues] of cathi-
none, a derivative of the khat plant [that was] used as a stimulant for
hundreds of years throughout the Middle East and Africa." 46 Like THC,
cathinone is also listed as a Schedule I drug,47 and the most common bath
salt ingredients-mephedrone (4-MMC), methylone, and methylenediox-
ypyrovalerone (MDPV)48-are all currently under a federal ban.4 9
Before the ban, bath salts could commonly be purchased at head shops,
at convenience stores, and via the Internet under names like "Bilss, Blue
Silk . . . Snow Leopard, Stardust, Vanilla Sky . . . [and] White Lighten-
ing."50 In addition to selling synthetic drugs as commonplace products
like bath salts, manufacturers are also marketing the drug as plant food,5'
pond cleaners, insect repellants, and vacuum fresheners. 52
With regards to the drug's effects, bath salts are reported to induce
sensations akin to controlled stimulants like cocaine, ecstasy (MDMA),
amphetamines, and LSD, and the drug can come in the form of a pill or a
"white, off-white, or slightly yellow-colored powder." 53 Like cocaine, syn-
thetic cathinones are ingested by snorting, but they can also be injected,
smoked, or swallowed.54 Users of the drug often seek to achieve feelings
of "increased arousal, sociability, . . . euphoria[,] . . . increased mental
focus, stimulation, and physical energy."55 Although the drug is chemi-
cally similar to illicit drugs that promote high energy and an upbeat
mood, bath salts can actually induce an array of extremely serious side
effects on the body, mind, and cardiovascular system, such as "tachycar-
dia, hypertension, hyperthermia[,] . . . peripheral vasoconstriction[,] ...
insomnia, depression, hallucinations, anxiety, psychosis, paranoia, confu-
sion, and excited delirium."56 Since the ingredients in bath salts are con-
stantly changing, its effects can be unpredictable, but many users
experience a high for about thirty minutes to two hours, with a "'come
down' phase" usually lasting between two and four hours.57 Another dan-
gerous aspect of bath salts is that, like cocaine and other stimulants, they
are highly addictive and induce serious withdrawals, adding an additional
threat to its consumers-many of whom are young, uninformed, or sim-
ply seeking a quick thrill.58 Recent data from the American Association
46. Duckworth, supra note 5, at 32-33.
47. 21 U.S.C. § 812(c)(10) (2006) (listing marijuana as a Schedule I drug); Schedules of
Controlled Substances, 21 C.F.R. § 1308.11(f)(3) (2012) (listing cathinone as a Schedule I
drug).
48. See Duckworth, supra note 5, at 33.
49. Establishment of Drug Codes for 26 Substances, 78 Fed. Reg. 664, 664 (Jan. 4,
2013) (to be codified at 21 C.F.R. pt. 1308).
50. BATH SALTS FAcr SHEEt, supra note 39.
51. See WHITE HOUSE FAcr SHEET, supra note 6.
52. See Duckworth, supra note 5, at 32.
53. BATH SALTS FAcr SHEET, supra note 39.
54. See id.






of Poison Control indicates that the drug has not simply caused a few
adverse reactions, but has negatively affected thousands of consumers na-
tionwide: "the number of calls related to bath salt exposure received by
poison control centers across the country increased by more than 20 times
in 2011 alone, up from 304 in 2010 to 6,138."59
C. EARLY ArrEMPTS OF SYNTHETIC DRUG REGULATION
AND THE "NFHC" LABEL
The present danger is that Spice and bath salts, which are basically
analogous in form and function to marijuana and cocaine, have become
legally sold and easily attainable. 60 The federal government has long been
aware of the existence of designer drugs and of the ability of chemists to
create various analogues, and Congress specifically attempted to subdue
the problem by enacting the Controlled Substances Analogue Enforce-
ment Act (AEA), which was added to the Controlled Substances Act
(CSA) in 1986.61 The AEA states: "[a] controlled substance analogue
shall, to the extent intended for human consumption, be treated, for the
purposes of any Federal law as a controlled substance in schedule I."62
Thus, although the AEA seemingly offers widespread legislative regula-
tion for the threat of synthetic drugs, the innocuous phrase "to the extent
intended for human consumption"63 created a technical loophole in a
sweeping federal regulation that soon allowed synthetic drug manufactur-
ers to weasel their way around the law and capitalize on a $5 billion-per-
year industry.64
To bypass U.S. Food and Drug Administration ("FDA") regulations
and the CSA, synthetic drug manufacturers have devised creative mar-
keting tactics wherein they literally package their chemicals as everyday
retail items such as herbal incense, potpourri, or bath salts-products that
also conveniently share similar outward appearances to synthetic mari-
juana, cocaine, and ecstasy.65 To loosely justify the notion that these items
are indeed household goods, manufacturers simply add a "not for human
consumption" ("NFHC") label on their product packaging. 66 Therefore,
"[t]he loophole through which many designer drugs slip is the fact that,
unless specifically banned, chemical substances labeled as 'not for human
consumption' are not considered drugs at all." 6 7 The fact that American
59. WHTTE HOUSE FAcr SHEET, supra note 6.
60. See id.
61. See Controlled Substances Analogue Enforcement Act, 21 U.S.C. § 813 (2006);
Bath Salts: The Synthetic Scare, supra note 40.
62. 21 U.S.C. § 813 (2006).
63. See id.
64. See Bath Salts: The Synthetic Scare, supra note 40; see also Rose, supra note 35
(noting that "sales in the synthetic drug industry seem to be growing-to roughly $5 billion
a year, according to Rick Broider, president of the North American Herbal Incense Trade
Association").
65. See WHITE HoUSE FACT SHEET, supra note 6; see also Duckworth supra note 5, at
32-34.




Poison Control Centers have been flooded with calls regarding synthetic
drugs proves that many of its consumers treat their adverse reactions as
poison exposure rather than drug overdoses. 68 Despite the covert meth-
ods employed by drug manufacturers, the reality remains that these prod-
ucts are not sold in salons or mainstream supermarkets. Instead, they are
found in tobacco stores and head shops, alongside smoking products and
pipes, with tag lines like "'[n]ever lets you down' and 'lab certified." 69
Furthermore, synthetic marijuana has even been sold in the form of
"prerolled cigarettes," which casts a large shadow of doubt and absurdity
on the marketing schemes of synthetic drug manufacturers and their
shoddy NFHC warnings. 70
In addition to improper marketing and labeling issues, government and
law enforcement agencies must also worry about the evolving science of
designer drug development. 7' Just as the NFHC label enables drug com-
panies to legally sell designer drugs in head shops and convenience stores,
these companies have also resiliently found ways to circumvent any drug
bans enacted by state or federal authorities.72 Physicians and DEA chem-
ists have described the struggle to stop manufacturers and ban their
newly minted substances as "'a cat and mouse game"' and as "'playing
whack-a-mole." 73 Essentially, each time legislators implement tempo-
rary bans on particular synthetic drug ingredients, chemists quickly sub-
stitute the banned ingredients with newly created analogues, thus
allowing them to thwart the law and continue business as usual.74 As a
result, chemists and "'narcopharmacologists are always a few steps ahead
of the authorities.'" 7 5 Furthermore, newly implemented bans inflame the
growing problems of regulating synthetic drug sales via the Internet and
the constant influx of unknown overseas ingredients while the DEA, U.S.
Customs and Border Protection, and other law enforcement agencies,
chemists, and forensic specialists wrestle with the challenge of identifying
unknown and mysterious substances. 76
68. See WHITE HOUSE FAct SHEET, supra note 6 (noting the increase in synthetic
drug-related calls received by the American Association for Poison Control from 2010 to
2011); see also Nok-Noi Ricker, Police Warn About 'Bath Salts': New Dangerous, Legal
Synthetic Drug, BANGOR DAILY NEWS (Mar. 11, 2011, 9:45 PM), http://bangordailynews.
com/2011/03/11/news/bangor/police-warn-about-bath-salts-new-dangerous-legal-synthetic-
drug/.
69. Chase Purdy, Unnatural Highs With Synthetic Drugs are Brutal and Legal, ROA-
NOKE TIMEs (May 16, 2012), http://www.roanoke.com/news/roanoke/wb/308849.
70. See Duckworth, supra note 5, at 34.
71. See WHITE HOUSE FACr SHEET, supra note 6.
72. See Knopf, supra note 8.
73. See id. (quoting H. Westley Clark, M.D., who described the synthetic drug war as
"'a cat and mouse game"'); see also Synthetic 'Bath Salts' An Evolving Problem for DEA,
NPR (June 30, 2012, 4:23 PM), http://www.npr.org/2012/06/30/156048262/synthetic-bath-
salts-an-evolving-problem-for-dea (quoting Arthur Berrier, a senior research chemist for
the DEA, who compared the problem to playing "'whack-a-mole"').
74. See Rose, supra note 35.
75. Knopf, supra note 8 (quoting H. Westley Clark, M.D.).
76. See WHITE HOUSE FACT SHEET, supra note 6; see also Rose, supra note 35.
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To worsen matters, these newly created analogues, which are made in
laboratories that have no regard for consistency, oversight, or quality
standards, have resulted in synthetic drugs that are much more potent
and dangerous than natural THC and the conventional stimulants these
drugs intend to mimic. 77 "While chemists attempt to avoid the restrictions
of governmental agencies, they are creating potentially hazardous, and
even lethal, new compounds."78 This unsettling fact has also put police
and healthcare providers on edge, as there is "no 'antidote'" for over-
doses, and users of synthetic drugs are prone to hallucinations and in-
creased energy as well as violent, agitated, and unpredictable behavior. 79
Moreover, physicians and emergency room staff are faced with the same
problem as government officials of trying to predict and identify what
synthetic ingredients a patient may have ingested since many analogues
are not readily detectable in standard drug tests.80
III. CURRENT STATE OF THE LAW
Synthetic drugs have not only instigated a surge of media speculation
and nationwide concern, but also pose an undeniable risk to public health
and safety,81 which leaves state and federal legislators with a very daunt-
ing task: fixing the problem. As of 2012, it was clear that the Analogue
Enforcement Act and the Controlled Substances Act were insufficient to
control the rapidly evolving nature of designer drugs and the under-
handed tactics of its manufacturers. 82 This Part chronicles current state
and federal regulatory initiatives and their effect on criminal law due to
the ongoing legal backlash amongst legislators, the DEA, synthetic drug
retailers, manufacturers, and consumers.
A. THE RACE TO BAN SYNTHETIC ANALOGUES
The NFHC label has allowed synthetic drug manufacturers and retail-
ers to supersede government oversight and establish an enormous, yet
surprisingly legal, designer drug empire.83 Although it is not possible to
automatically halt synthetic drug production, both the U.S. government
and the DEA have worked to enact legislation that aims to counteract
and control the recent designer drug boom.84 In addition to dodging CSA
77. See Rose, supra note 35 ("Christine Stork, the clinical director of the Upstate New
York Poison Control Center, says that she's seen a steady stream of synthetic marijuana
users turn up in emergency rooms over the past few years" and that "synthetic marijuana
can be 20 times as potent as real marijuana."); see also WHITE HOUSE FACr SHEET, supra
note 6.
78. Quan, supra note 22, at 239-40.
79. See Duckworth, supra note 5, at 36.
80. See id. at 32.
81. See WHIrE HOUSE FACT SHEET, supra note 6.
82. See id. (outlining federal government efforts to enact legislation and temporarily
classify identified synthetic analogs as Schedule I drugs).
83. See Bath Salts: The Synthetic Scare, supra note 40.
84. See WHITE HOUSE FAcT SHEET, supra note 6; see also News Release, Office of
Nat'l Drug Control Policy, White House Drug Policy Director Convenes Federal Agencies
[Vol. 66410
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laws, the synthetic drug industry has capitalized on the fact that enacting
federal legislation is a colossal and slow-moving process that allows retail-
ers to still make profits in the interim of governmental regulatory at-
tempts; however, federal efforts have resulted in the adoption of the
Synthetic Drug Abuse Prevention Act of 2012 (SDAPA)-a powerful
legislative tool that offers nationwide control and hopes to end the syn-
thetic drug "cat and mouse game."85
The U.S. government first encountered the issue of K2 and Spice in
November 2008,86 which was much too early to predict its widespread
future repercussions and actualize adequate oversight. As a result, there
were no state or federal regulations in place that controlled or impeded
the production of synthetic cannabinoids or bath salts before 2010.87 The
most adequate combative measure was to place currently identified ana-
logues under a temporary ban so that the government could at least cur-
tail any identified ingredients in Spice and bath salts.88 The DEA is
largely in charge of controlling drug trafficking and enforcing the CSA, 89
which classifies drugs as controlled substances by categorizing them as
Schedule I through Schedule V. Schedule I means "high potential for
abuse . . . no currently accepted medical use," and "a lack of accepted
safety for use of the drug . .. under medical supervision," while Schedule
V means there is "low potential for abuse" compared to the Schedule
I-IV drugs and "a currently accepted medical use . . . in the United
States," together with little chance of "physical or psychological depen-
dence." 90 Temporary drug bans are made possible through the Compre-
hensive Crime Control Act of 1984,91 which amended the CSA to allow
the Attorney General to "temporarily place a substance into Schedule I
of the CSA for one year" if such action is needed to "avoid imminent
hazard to the public safety."92 These emergency bans have the possibility
of being extended from the one-year limit for an extra six months if there
are current proceedings pending to permanently schedule the substance
under 21 U.S.C. § 811(a)(1). 93
to Discuss Threat of Synthetic Drugs, a.k.a. "Spice" and "Bath Salts" (Sept. 07, 2011)
[hereinafter White House Drug Policy Press Release], available at http://www.whitehouse.
gov/ondcp/news-releases-remarks/white-house-drug-policy-director-convenes-federal-agen
cies.
85. See Synthetic Drug Abuse Prevention Act of 2012, Pub. L. No. 112-144, 126 Stat.
993 (2012); Rose, supra note 35.
86. See WHITE HOUSE FACT SHEET, supra note 6.
87. Id.
88. See id.
89. See State & Local Task Forces, DEA, http://www.justice.gov/dea/ops/taskforces.
shtml (last visited Apr. 14, 2013).
90. 21 U.S.C. § 812(b)(1)(A-C) (2006) (defining Schedule I drugs); 21 U.S.C.
§ 812(b)(5)(A-C) (2006) (defining Schedule V drugs).
91. See 21 U.S.C. § 811(h) (2006).
92. See Schedules of Controlled Substances: Temporary Placement of Five Synthetic
Cannabinoids Into Schedule I, 76 Fed. Reg. 11,075, 11,075 (Mar. 1, 2011) (codified at 21
C.F.R. pt. 1308) (note that the Attorney General has delegated authority to implement




Although there was no regulatory enforcement as of 2010, on Novem-
ber 24, 2010, the DEA Administrator initiated the temporary ban process
by filing a notice of intent to classify five synthetic cannabinoids as Sched-
ule I drugs.94 The DEA's action to ban the five synthetic substances be-
came a final order on March 1, 2011, and was published in the Federal
Register to inform the public that "the manufacture, distribution, posses-
sion, importation, and exportation of these synthetic cannabinoids"
would result in the same "criminal, civil and administrative penalties" im-
posed for Schedule I drugs.95 The emergency ban was considered a cata-
lyst against the synthetic drug war, though it would take larger legislative
efforts to aid the states in subduing the use of a popular product, whose
industry was allowed to thrive due to its long-held status of being in "le-
gal limbo." 96 Also, on September 7, 2011, the White House Drug Policy
Director Gil Kerlikowske acknowledged that designer drugs were a sub-
ject of national concern and met with federal agency representatives from
the DEA, the FDA, the Centers for Disease Control, the Department of
Homeland Security, and prominent drug-control organizations to address
the serious impacts of synthetic drugs on national health and safety. 9 7 The
DEA's mission against bath salts materialized on October 21, 2011, when
a final order was issued to temporarily classify three types of synthetic
cathinones as Schedule I drugs: mephedrone, methylone, and MDPV.98
The eminence of synthetic drugs and the keen, steadfast nature of its
manufacturers increased national tension to the point that "[1]ocal police
agencies . . . called on Congress to make it easier for the DEA to quickly
ban substances because it's so easy for drug manufacturers to switch
chemicals. Currently, it can take years for the DEA to permanently ban a
substance." 99 On December 8, 2011, Congress began laying the ground-
work for SDAPA when the U.S. House of Representatives approved
H.R. 1254 (with a 317-98 vote), which sought to ban bath salts, K2, and
other synthetic compounds, and proposed to further increase the DEA's
temporary ban authority by extending the ban period from its regular
one-year period (with a possible six-month extension) to a three-year pe-
riod, in hopes of giving the DEA more time to study and regulate possi-
ble harmful substances. 100 Although H.R. 1254 was never adopted into
94. See id. (intending to temporarily classify JWH-018, JWH-073, JWH-200, CP-
47,497, and cannabicyclohexanol as Schedule I drugs).
95. Id.
96. Bill Chapel, DEA Bans 'Fake Pot' Products That Emulate Marijuana, NPR (Mar.
1, 2011, 12:49 PM), http://www.npr.org/blogs/thetwo-way/2011/03/01/134164794/dea-bans-
fake-pot-products-that-emulate-marijuana.
97. White House Drug Policy Press Release, supra note 84.
98. Schedules of Controlled Substances: Temporary Placement of Three Synthetic
Cathinones Into Schedule I, 76 Fed. Reg. 65,371, 65,371 (Oct. 21, 2011) (codified at 21
C.F.R. pt. 1308).
99. Kevin Diaz, U.S. House Backs 'Bath Salts' Ban, STAR TRIBUNE (Dec. 8, 2011,
11:43 PM), http://www.startribune.com/politics/national/135263538.html.
100. See Synthetic Drug Control Act of 2011, H.R. 1254, 112th Cong. (2011); Jim
Abrams, House Votes to Ban Synthetic Drugs Sometimes Marketed as 'Bath Salts' and
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law,10' the U.S. Senate soon followed suit and organized its own propos-
als to combat designer drugs.102 On May 24, 2012, with a nearly unani-
mous vote of 96-1, the Senate approved the FDA Safety and Innovation
Act, which contained an amendment that was the precursor to SDAPA,
and, like H.R. 1254, it intended to classify various synthetic substances as
Schedule I drugs and increase the length of emergency bans.'03 The
House and Senate eventually abridged their differing proposals and
agreed to criminalize twenty-six types of synthetic marijuana and cathi-
none formulations and increase the DEA's regulatory authority by
broadening the duration of temporary bans.104 A congressional consensus
was finally attained on June 26, 2012, when the House also approved the
FDA Safety and Innovation Act, which was subsequently signed into law
by President Obama on July 9, 2012.105
After months of national concern, media speculation, and political
strategizing, Congress and the President unveiled the Synthetic Drug
Abuse Prevention Act of 2012, a law that largely counteracted synthetic
drugs by classifying popular analogues that were already under former
DEA emergency bans into the Schedule I category.106 Before the imple-
mentation of SDAPA, the DEA placed eight analogues under a tempo-
rary ban: five types of synthetic cannabinoids commonly found in Spice
products, and three synthetic cathinones, which at the time were the most
popular ingredients in bath salts.'07 Furthermore, the DEA planned to
initiate proceedings pursuant 21 U.S.C. § 811(a)(1) to extend the syn-
thetic cannabinoid bans by the statutory six-month period; however,
SDAPA rendered these attempts unnecessary since it broadly placed
many of the substances that the DEA hoped to outlaw into the Schedule
I category.108 With regards to its specific legislative changes, SDAPA adds
a new section entitled "Cannabimimetic Agents" under the CSA's list of
Schedule I substances, wherein the new list names fifteen different ana-
logues cited by chemical composition and includes the most often-abused
variations of synthetic marijuana.109 SDAPA also adds eleven chemical
compounds to a section entitled "Other Drugs," which includes
'Plant Food', HUFFINGTON POST (Dec. 8, 2011, 3:46 PM), http://www.huffingtonpost.com/
2011/12/08/synthetic-drugs-ban-house n_1137322.html (last updated Dec. 8, 2011).
101. See H.R. 1254 (112th): Synthetic Drug Control Act of 2011, GOVTRACK.Us, http://
www.govtrack.us/congress/bills/112/hrl254 (last updated Dec. 8, 2011).
102. See Nok-Noi Ricker, US Senate Votes to Ban Bath Salts, Synthetic Marijuana, BAN-
GOR DAILY NEWS (May 29, 2012, 8:14 PM), http://bangordailynews.com/2012/05/29/poli
tics/us-senate-votes-to-ban-bath-salts-synthetic-marijuana.
103. See Food and Drug Administration Safety and Innovation Act, S. 3187, 112th
Cong. §§ 1151-52 (2012) (enacted).
104. See DEA News Release 2, supra note 11.
105. See S. 3187 (112th): Food and Drug Admin. Safety & Innovation Act, Gov-
TRACK.Us, http://www.govtrack.us/congress/bills/112/s3187 (last updated Jun. 27, 2012).
106. See Establishment of Drug Codes for 26 Substances, 78 Fed. Reg. 664, 664 (Jan. 4,
2013) (to be codified at 21 C.F.R. pt. 1308).
107. Id.
108. See id.




mephedrone and MPDV, the main additives found in bath salts.110 How-
ever, methylone, a prominent analogue used in bath salts, was not perma-
nently labeled within the Schedule I list like the other twenty-six
substances but was added to a temporary ban list, which was effectuated
by final order on January 04, 2013.111 Lastly, SDAPA amends the CSA's
temporary ban provision to increase emergency bans from one year to a
new baseline period of two years, with the possibility of a one-year exten-
sion, therefore instituting a maximum temporary ban period of three
years. 112
Although advocates and legislators anticipated that the SDAPA would
be a powerful regulatory weapon against popular drugs that allure, capti-
vate, and threaten the American public, there is still ample concern that
the quickly adapting nature of designer drugs has caused lawmakers to
again remain one step behind the crafty chemists that formulate these
drugs.113 While some members of Congress are confident that widespread
prohibitions will promote public safety and allow the law to "'stay[ ] one
step ahead of the criminals,"'1 14 others feel as though the law is practi-
cally null and void.115 In fact, media reports outlining public skepticism
were already flourishing in the days before and after the SDAPA's effec-
tuation:" 6 "A federal ban on synthetic drugs, signed into law by Presi-
dent Obama . .. was obsolete before the ink of his signature dried. Drug
formulations not covered by the law's language, and almost certainly syn-
thesized in direct response to legal pressure, are already on sale."117 The
SDAPA does not instill fear or caution into those straddling the bounda-
ries of legality; rather, synthetic drug retailers and their advocates con-
tinue to defy federal efforts and even boastfully point out the SDAPA's
shortcomings.1 18 Moreover, law enforcement officials, politicians, and
DEA agents have already expressed exasperation and worry that the
SDAPA will result in yet another legislative misfire due to its narrow reg-
110. Id. at 1131-32.
111. See Establishment of Drug Codes for 26 Substances, 78 Fed. Reg. at 664, 666.
112. See Synthetic Drug Abuse Prevention Act § 811(h)(2), 126 Stat. at 1132.
113. See Rose, supra note 35; see also Phillip Smith, US Senate Passes Synthetic Drug
Ban, Without Mandatory Minimums, STOPTHEDRUGWAR.ORG (May 30, 2012, 5:30 PM),
http://stopthedrugwar.org/chronicle/2012/may/30/us-senate-passessynthetic -drug.
114. News Release, U.S. Senator Christopher Coons, Senator Coons Votes to Send
"Bath Salts" Ban to President for Signature (June 26, 2012) [hereinafter Sen. Coons News
Release], available at http://www.coons.senate.gov/newsroom/releases/release/senator-
coons-votes-to-send-bath-salts-ban-to-president-for-signature- (quoting U.S. Senator
Christopher Coons (D-Del.), who joined the majority of Senators in approving S. 3187 and
stressed the importance of federal legislation in the fight against synthetic drugs).
115. See Rose, supra note 35.
116. Id.; Smith, supra note 113; see also Federal Synthetic Drug Ban Filled With Future
Loopholes, REHABINFO (Oct. 21, 2012), http://www.rehabinfo.net/blog/federal-synthetic-
drug-ban-filled-with-future-loopholes/.
117. Brandon Keim, New Federal Ban on Synthetic Drugs Already Obsolete, WIRED
(July 12, 2012, 3:30 PM), http://www.wired.com/wiredscience/2012/07/synthetic-drug-ban/.
118. See Smith, supra note 113.
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ulation of bath salt ingredients.119 During negotiations, the DEA pro-
posed a list of forty-one substances that it hoped would be classified as
Schedule I drugs, including seventeen bath salt ingredients. 120 Neverthe-
less, the SDAPA selectively encompasses twenty-six substances, only two
of which are bath salt ingredients and which were already controlled
under the temporary bans anyway.12 1 Despite finalized regulations and
public criticism, legislators and designer drug supporters still perpetuate
their battles as they both project marked optimism on their opposing
stances, with New York Senator Charles Schumer touting the SDAPA as
"'the final nail in the coffin for the legal sale of bath salts,"' whereas
scientists continue to verify the existence of similar chemical concoctions
that would still legally escape the SDAPA's graspl 22-facts that create
further uncertainty about the future of synthetic drugs.
B. SYNTHETIC DRUGS AND CRIMINAL LAW:
LEGAL TODAY, ILLEGAL TOMORROW
In the midst of federal legislative undertakings, several states have also
prompted their own drug bans and have not only taken an active regula-
tory role in eradicating the prevalence of these drugs, but have also
joined forces with federal agencies to aggressively target and prosecute
synthetic drug retailers, consumers, and distributors.12 3 When the DEA
initially placed five synthetic cannabinoids under a temporary ban in
March 2011, roughly sixteen states had taken action against certain syn-
thetic chemicals.124 As of November 2012, forty-five states plus Puerto
Rico had enacted bans targeting certain types of synthetic cannabinoids,
synthetic cathinones, or both. 12 5 The constant modification of designer
drug formulations has instigated an avalanche of individual state bans
that have also been changing in scope and substance to squelch the prob-
lem.126 Thus, synthetic drugs have created a legal cataclysm within the
areas of commercial and criminal law, sparking national raids and con-
demnatory lawsuits, as well as the arrests of retailers and consumers,
many of whom assumed the substances were legal at the time of their




121. See Synthetic Drug Abuse Prevention Act of 2012, Pub. L. No. 112-144, § 1152,
126 Stat. 993, 1130-32 (listing twenty-six compounds as Schedule I, with Mephedrone and
MPDV being the only prohibitions affecting bath salts); see also Goldman, supra note 119.
122. See Keim, supra note 117 (noting that a toxicologist personally tested two synthetic
drug compounds, UR-144 and XLR-11, which are currently available for public sale as
herbal incense products, and also quoting a U.S. Senator's opinion on the SDAPA).
123. See DEA News Release 1, supra note 9.
124. See Press Release, DEA, Chemicals Used in "Spice" and "K2" Type Products Now
Under Federal Control and Regulation (Mar. 1, 2011), available at http://www.justice.gov/
dea/pubs/pressrel/pr030111.html.
125. See Synthetic Drug Threats, NATIONAL CONFERENCE OF STATE LEGISLATURES,





To retaliate, state and federal authorities have focused on subduing
what many consider a primary stronghold in the synthetic drug arena:
retailers and manufacturers.12 8 Excluding the Internet, convenience
stores and head shops are the primary vendors of herbal incense and bath
salt products.129 In addition to legislative pressures, the National Associa-
tion of Convenience Stores ("NACS") warned 148,000 of its participating
retailers to stop selling synthetic drug products, though many retailers did
not heed this advice.130 Furthermore, in July 2012, New York Attorney
General Eric Schneiderman began his own crusade against local retailers
when he sued twelve different head shops for allegedly violating New
York's labeling statutes by selling deceptively packaged drugs.13 Though
some of the decisions are currently pending, Schneiderman's efforts pro-
cured several injunctions against the retailers, forcing them to cease sell-
ing all improperly labeled drug products. 132 For example, following an
undercover investigation, a $15,000 fine and a permanent injunction were
issued against the owner of two New York head shops for violating label-
ing laws by selling ambiguously packaged synthetic drugs with NFHC la-
bels posing as air fresheners and products used to make whipping
cream.133 The order was issued by Justice Kevin K. Ryan, who likened
the sale of improperly labeled designer drugs to engaging in fraudulent
activity, and further stated: "[I]t staggers the imagination to believe [the
products] were not intended to be consumed .... Simply put, the respon-
dent offered over the counter drugs for sale without providing the con-
sumer with much of the information required by law." 134
The sale of synthetic drugs can result in varied civil and criminal allega-
tions that are far more complex than the usual charges of mere possession
or possession with intent to distribute substances that violate state or fed-
127. See State v. Nickel, 806 N.W.2d 155, 156-57 (N.D. 2011); State v. Brotherton, No.
12-0969 (N.Y. Sup. Ct. Oct. 23, 2012), http://www.ag.ny.gov/press-release/ag-schneiderman-
wins-court-victory-push-ban-mislabeled-drugs-head-shops (follow "click here to read the
decision in full" hyperlink) (order granting permanent injunction); see also Michael Kelley,
Lawyer: The National Synthetic Drug Crackdown Won't Hold Up In Court, Bus. INSIDER
(Jul. 31, 2012, 1:57 PM), http://www.businessinsider.com/lawyer-the-national-synthetic-
drug-crackdown-wont-hold-up-in-court-2012-7.
128. See DEA News Release 1, supra note 9; see also Press Release, A.G. Eric T.
Schneiderman, A.G. Schneiderman Wins Court Victory In Push To Ban Mislabeled Drugs
From Head Shops (Oct. 25, 2012) [hereinafter Schneiderman Press Release], available at
http://www.ag.ny.gov/press-release/ag-schneiderman-wins-court-victory-push-ban-misla-
beled-drugs-head-shops.
129. See DEA News Release 1, supra note 9.
130. See Nationwide Crackdown Commences on Synthetic Drugs, NACS ONLINE (Jul.
27, 2012), http://www.nacsonline.com/NACS/News/Daily/Pages/ND0727122.aspx.
131. See Schneiderman Press Release, supra note 128.
132. See id.
133. See State v. Brotherton, No. 12-0969 (N.Y. Sup. Ct. Oct. 23, 2012), http://www.ag.
ny.gov/press-release/ag-schneiderman-wins-court-victory-push-ban-mislabeled-drugs-head-
shops (follow "click here to read the decision in full" hyperlink) (order granting permanent
injunction); see also Schneiderman Press Release, supra note 128.
134. See Schneiderman Press Release, supra note 128.
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eral drug statutes.135 For example, on March 4, 2012, in Atlanta, Georgia,
David Burnett found his sixteen-year-old son, Chase, dead in their backy-
ard hot-tub. 3 6 An open bag of synthetic marijuana consisting of AM-
2201 was found next to the boy, and an autopsy showed that the boy died
from consuming the drug.'37 The product was branded as potpourri called
"Mojo Diamond Extreme 100x," and it also had a NFHC label.138 The
Burnetts filed a complaint against the product manufacturer, Omerta
Labs, LLC, and Lunar Labs, LLC, and its owner, Peyton Palaio, wherein
they stated that the defendants' negligence was the proximate cause of
their son's death.139 They further asserted claims of strict liability, negli-
gence per se, and a violation of the Georgia racketeering statute.140 Simi-
larly, two men in Houston have been charged for selling synthetic
marijuana products that resulted in the deaths of two teen boys in North
Dakota.141 The men face federal conspiracy charges in connection with
the deaths.142 Specifically, the complex importation of the drugs has been
traced to China, Canada, and Great Britain, with the drugs eventually
being sold via the Internet to dealers, who in turn sold the dangerous
substances to the two deceased teenagers.143
Following the passage of the SDAPA, the DEA heightened its strategy
by joining forces with state, local, and federal agencies to stage an attack
against synthetic drug retailers, wholesalers, and manufacturers.1 4 4 On
July 26, 2012, the DEA celebrated a victory when it executed a sweeping
synthetic drug raid called Operation Log Jam.145 This noteworthy opera-
tion was the first antisynthetic drug crime enforcement scheme ever to
take place on a national scale and was made possible through an expan-
sive collaboration involving U.S. Immigration and Customs Enforcement
(ICE), U.S. Customs and Border Protection, the U.S. Postal Inspection
Service, the FBI, the IRS, the FDA, and several state and local crime
enforcement units from 109 cities across the country.146 After executing
over 265 search warrants, 29 of which were for manufacturing facilities,
Operation Log Jam resulted in 91 nationwide arrests and an astounding
array of seizures-"4.8 million packets of synthetic cannabinoids and the
products to produce nearly 13.6 million more, as well as 167,000 packets
of synthetic cathinones, and the products to produce an additional
135. See Complaint at 16, 36, 56, 69, Burnett v. Palaio, No. 2012-cv-220542, 2012 WL
3835824 (Ga. Super. Ct. Aug. 24, 2012).
136. See id. at 9.
137. Id. at 10, 16.
138. Id. at 10-13.
139. Id. at 28.
140. Id. at 51, 63, 73-76.
141. Houston-Area Men Charged in Synthetic Drug Deaths of Teens, Hous. CHRON.









392,000 [and] ... $36 million dollars in cash, 53 guns, and almost $6 mil-
lion in assets."147
The recent outpouring of state bans has confused consumers and cre-
ated a realm of uncertainty where possession of the legally ambiguous
substances can be permissible one day, yet rendered a felony offense the
next.148 For example, in State v. Nickel, a North Dakota Supreme Court
case, Nickel was charged with various counts of violating the state's Uni-
form Controlled Substances Act due to his possession of synthetic sub-
stances that were outlawed pursuant to a recent emergency interim rule
banning seven synthetic substances, including certain cannabinoids and
mephedrone. 149 Nickel was charged with violations occurring in May,
July, and August of 2010, and although the ban had an effective date of
February 26, 2010, the final rule had not been properly publicized and
was not added to the state's Administrative Code until October 2010.150
The trial court granted Nickel's motion to dismiss, concluding that the
rule was invalid at the time of Nickel's crimes because the North Dakota
Board of Pharmacy (the "Board") failed to follow the proper procedure
required to adequately notify the public; the North Dakota Supreme
Court affirmed.151 To effectuate adequate notice of emergency rules, the
state statute simply directs that an "'agency shall take appropriate mea-
sures to make interim final rules known to every person who may be
affected by them." 152 The Board argued its compliance based on the fact
that the state Attorney General held a press conference after the rule's
adoption. Although several news outlets heavily publicized the ban,
neither the media nor the state ever publicized a complete list of the ex-
act seven substances that were criminalized until the October 2010 state
code publication.153 Additionally, the Board claimed that several of its
agents informed businesses in nine different cities about the new rule, but
none of the businesses were given documentation of the rule's scope or
technicalities, and the Board had even failed to give a copy of the rule to
the state's criminal investigation unit.154 Though the court acknowledged
that media publications informed the public about how to obtain a copy
of the rule, it also recognized that none of the sources pointed out the
very important fact that the rule was presently in effect. 55 In concluding
that the state failed to meet its burden, the court rightfully reasoned that
the "rule imposed grave consequences on the general public" and
147. Michele M. Leonhart, DEA Admin., Remarks at the Operation Log Jam Press
Conference, DEA Headquarters (July 26, 2012) [hereinafter Log Jam Press Conference],
available at http://www.justice.gov/dea/pr/speeches-testimony/2012-2009/120726_op-log-
jam.pdf.
148. See State v. Nickel, 806 N.W.2d 155, 159-60 (N.D. 2012).
149. Id. at 156-57.
150. Id. at 157.
151. Id. at 156-57.
152. Id. at 158 (citing N.D. CENT. CODE ANN. § 28-32-03(5) (West 2009)).
153. Id. at 159.
154. Id. at 157, 159.
155. Id. at 159.
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"turned any person's purchase, sale or possession of lawful products into
felony level offenses overnight." 156
By contrast, comparable facts brought about a very different outcome
in Haag v. State, which is also a North Dakota Supreme Court case.157 In
Haag, the defendant hoped to achieve an outcome similar to Nickel after
he petitioned for post-conviction relief on the grounds that he pled guilty
to a crime that was unenforceable at the time. 58 Specifically, on Novem-
ber 12, 2010, Christopher Haag was arrested for possession and intent to
distribute a synthetic cannabinoid (JWH-018) that was banned under
North Dakota's emergency ruling in October 2010; Haag pled guilty in
May 2011.159 In making his claim, the defendant mistakenly argued that
the Board's emergency interim rule was rendered void under State v.
Nickel.160 The North Dakota Supreme Court rejected this argument and
denied post-conviction relief, stressing that the issue in Nickel was
whether the Board adequately alerted the public of the ban-an issue
that was resolved in October 2010-when the emergency rule became
permanent and the illicit formulations were publicized in the Administra-
tive Code. 161 Conversely, the pertinent issue in Haag was simply whether
the crimes were committed prior to October 2010.162 But because Haag's
violations occurred in November 2010, the court determined that he had
to endure the full extent of the law despite the fact that these convictions
could have been dodged had they occurred just a short time prior to the
rule's finalization. 16 3
Apart from issues concerning time-sensitive convictions and adequate
public notice of new bans, synthetic drugs have also brought up questions
of statutory interpretation and even constitutional law. 164 In State v.
Beaudette, a Louisiana case, Cody Beaudette appealed the district court's
denial of his motion to quash a conviction for possession of JWH-210, a
synthetic cannabinoid that was not specifically listed as a Schedule I drug
at the time of his offenses on March 16 and March 24, 2011, respec-
tively. 165 Nevertheless, the relevant state statute broadly criminalized the
possession or distribution of any Schedule I controlled substances or ana-
logues of Schedule I substances, wherein an "analogue" was vaguely de-
fined as any compound that shares a "substantially similar" chemical
156. Id.
157. Compare Haag v. State, 823 N.W.2d 749, 750 (N.D. 2012) (denying post-conviction
relief and affirming criminal convictions for synthetic drug possession and intent to dis-
tribute), with State v. Nickel, 806 N.W.2d 155, 156 (N.D. 2012) (affirming the dismissal of
criminal charges for synthetic drug possession).
158. See Haag, 823 N.W.2d at 750.
159. Id.
160. See id. at 750-51.
161. Id.
162. Id.
163. See id. at 752.
164. See State v. Beaudette, 2012-0871 (La. App. 1 Cir. 7/13/12), 97 So.3d 600, 603-04,
writ denied, 2012-2162, 99 So. 3d 679.
165. See id. at 602 (referencing LA. REv. STAT. ANN. § 40:966(A)(1) (2012)).
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structure with a Schedule I or Schedule II drug.166 The defendant made
three claims: First, they claimed that the district court misinterpreted
Louisiana statute § 40:966(A)(1) by labeling JWH-210 an illegal sub-
stance without regard for whether it was a Schedule I drug, and second,
they claimed that because JWH-210 was not listed as Schedule I at the
time of the offense (but was subsequently listed as Schedule I on July 15,
2011), the defendant suffered an ex post facto conviction in violation of
his state and federal constitutional rights.167 Although the court high-
lighted that an expert witness (an organic chemist) verified that JWH-210
was indeed an analogue to Schedule I drug JWH-018, the defendant fur-
ther argued that the expression "substantially similar" was "unconstitu-
tionally vague" since the statute failed to outline quantifiable definitions
and "the necessary relationship between the chemical structure and the
effect of the parent drug and its alleged analogue."168 Beaudette also
claimed that broad blanket terms in the state statute led to one-sided
convictions, and the fact that an organic chemist was required to classify
the drug proved that the general public would have no way of discerning
the illegality of the substance.169 The court quickly dismissed the defen-
dant's arguments and held that the law was not retroactively applied since
the statute's mention of "analogues" encompassed JWH-210.170 While
the court conceded that the phrase "substantially similar" was not de-
fined in the statute, it still denied the constitutional law claim on the vul-
nerable conclusion that the statute did offer proper public notice, and
that criminalization of certain types of synthetic marijuana would allow
citizens to easily deduce the illegality of other comparable products.171
Although controlling case law involving synthetic drugs is still being
carved out, Nickel, Haag, and Beaudette currently confirm that the out-
comes of criminal cases involving synthetics can be as unpredictable and
varied as the substances themselves.
IV. ANALYSIS
Since their 2010 debut, designer drugs have not only sparked national
curiosity, outrage, and concern, but they have also instigated colossal reg-
ulatory feats, such as the SDAPA and Operation Log Jam.172 Addition-
ally, these drugs have forged a plethora of legal and criminal liabilities.
Despite widespread regulatory commotion, designer drugs-much like
the original drugs they intend to mimic-still remain a lingering
problem.'73
166. See id. (referencing LA. REv. STAT. ANN. § 40:961(8) (2012)).
167. See id. at 602-03. The court notes that "ex post facto laws are prohibited by Article
I, sections 9 and 10 of the United States Constitution and Article I, section 23 of the Loui-
siana Constitution." Id. at 603.
168. Id. at 604.
169. Id. at 603.
170. Id.
171. Id. at 604.
172. See WHim HOUSE FACT SHEET, supra note 6; DEA News Release 1, supra note 9.
173. See Keim, supra note 117; see also Kelley, supra note 127.
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A. ARE BLANKET BANS A PROBLEM OR A SOLUTION?
Congress and state and federal law enforcement agencies have ex-
pressed that bans and legislation are the solutions to the nation's designer
drug problem.174 While these dangerous and addicting substances do ne-
cessitate regulatory action, there are still those who oppose the strategic
counter-tactic of simply imposing rampant and vaguely-worded bans that
aim to encompass any new or unknown analogue that might material-
ize-a measure that could bring about legal injustices and other signifi-
cant consequences.175
For example, the DEA viewed Operation Log Jam as a triumphant
move against the synthetic drug industry-a collaborative and heroic op-
eration that resulted in the nationwide crackdown of criminals and drug-
dealers.176 On the other hand, critics consider the event to be nothing
more than an act of hasty arrests and reckless government overreach-
ing.177 While the criminal outcome of this raid has yet to be sorted out, a
DEA Press Release concerning Operation Log Jam concedes that many
of the confiscated substances were not expressly scheduled in the CSA.178
Nevertheless, the DEA stated that it intends to criminally prosecute these
alleged offenders under the Analogue Enforcement Act (AEA), which
would allow the DEA to treat the substances as criminal "if they are
proven to be chemically and/or pharmacologically similar to a Schedule I
or Schedule II" drug.' 79 Interestingly, the DEA Log Jam Press Release
mysteriously makes no mention of the SDAPA, which was passed only a
few days prior to the raid, nor does it mention whether any of the sub-
stances were covered under the SDAPA legislation.180 The DEA's release
relies solely on AEA provisions in hopes of successful convictions,181
which might be yet another indirect indicator that the SDAPA is indeed
already obsolete.182 Moreover, Spencer Siegel, a criminal defense attor-
ney who has organized a group of lawyers and scientists to advocate for
Operation Log Jam defendants, predicts that many of the charges will be
dismissed in court.183 Specifically, he claims that UR-144, a compound
used in many of the seized herbal incense products, was in fact legally
compliant at the time of the raid because the compound differs in both
structure and effect from the scheduled drugs listed in the AEA.184 Just
as State v. Nickel acknowledged that widespread bans can immediately
174. See DEA News Release 1, supra note 9; see also Sen. Coons News Release, supra
note 114.
175. See Kelley, supra note 127.
176. See Log Jam Press Conference, supra note 147.
177. See Kelley, supra note 127.
178. DEA News Release 1, supra note 9.
179. Id.; see also 21 U.S.C. § 813 (2006).
180. See DEA News Release 1, supra note 9.
181. See id.
182. See Smith, supra note 113.




morph lawful behavior into felony violations,185 critics and head shop
owners also wonder whether the DEA simply intends to condemn retail-
ers and entrepreneurs as dangerous and morally reprehensible drug-
pushers.186 It is undeniable that synthetic drugs have sparked controversy
and chaos, and that state and federal governments rightfully wish to exer-
cise their police powers to hold people legally accountable,'8 7 but the per-
secution of newly developed and technically legal synthetics further raises
the issue of whether law enforcement agents are simply conflating what is
illegal with what is immoral and socially unethical. Therefore, it is up to
the judiciary to take the utmost care in analyzing these cases to ensure
that any convictions are firmly grounded in the law-an analysis that will
necessitate scientific experts, meticulous statutory scrutiny, and special
attention to the wording and descriptions of the bans.' 88
Additionally, blanket bans trigger serious and time-sensitive criminal
penalties, which require extensive inquiry into the specificity of the ban
and whether the public had adequate knowledge of these newly criminal-
ized substances.189 Thus, the "cat and mouse"190 struggle is further per-
petuated in the courtroom when states and law enforcement agencies
lobby for the condemnation and conviction of synthetic drug possessors,
who they consider to be criminals and lawbreakers, while defendants
counterargue that they are lawful entrepreneurs or consumers who sim-
ply fell prey to abrupt criminalization.191 There is also the important ca-
veat of adequate notice, since many consumers were under the belief that
the substances they purchased were legal at the time (and many if not all
of the substances were legal at some point)-an issue that is further mud-
dled by NFHC labels.192
Moreover, the defendant in State v. Beaudette brings up the pertinent
concern that no one-not a police officer, judge, or even a chemist-can
determine the illegality of a substance based on human sight or sense
alone; the determination requires chemists, lab equipment, and expert
185. See State v. Nickel, 806 N.W.2d 155, 159 (N.D. 2012).
186. See Kelley, supra note 127; see also DEA News Release 1, supra note 9 (condemn-
ing the synthetic drug industry as complex, criminal drug trafficking schemes whose retail-
ers have "'scant regard for human life"').
187. See Seratt v. Oliver, No. 1:11CV00126 SNLJ, 2012 WL 645823, at *1 (E.D. Mo.
Feb. 28, 2012) (referring to a proposed Missouri state ban on certain synthetic compounds
as a mere exercise of state police power aimed at avoiding the proliferation of harmful
drugs).
188. See United States v. Hodge, 321 F.3d 429, 437 (3d Cir. 2003) (analyzing the AEA
and noting that interpreting "ambiguous criminal statutes" requires "close heed to lan-
guage, legislative history, and purpose in order to strictly determine the scope of the con-
duct the enactment forbids"); see also State v. Beaudette, 2012-0871 (La. App. 1 Cir. 7/13/
12), 97 So. 3d (requiring the use of an organic chemist to verify whether a synthetic drug
qualified as a controlled substance analogue within a state statute), writ denied, 2012-2162
(La. 11/2/12), 99 So. 3d 679.
189. See State v. Nickel, 806 N.W.2d 155, 158-60 (N.D. 2012).
190. Rose, supra note 35.
191. See Beaudette, 97 So. 3d at 602; see also Michael Kelley, Former Narcotics Officer
Says the DEA's Synthetic Drug Raid Was a Fiasco, Bus. INSIDER (Aug. 5, 2012, 7:22 AM),
http://www.businessinsider.com/raided-head-shop-owner-says-he-followed-the-law-2012-8.
192. See Rose, supra note 35.
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knowledge. 193 The Beaudette court accepts a careless and potentially dan-
gerous argument in holding that the defendant did indeed have "ade-
quate notice" because consumers should assume the illegality of a
substance based on the fact that similar products have also been out-
lawed. 194 This holding is almost as ill-conceived as that of the North Da-
kota Board of Pharmacy in State v. Nickel, which relies heavily on the
publicity of third-party newspaper and media reports to support the con-
clusion that the public was adequately alerted about the criminalization
of seven synthetic drugs.195 Issues of proper notice and the ability to dis-
cern a drug's illegality are echoed by Eric Vandervert, a head shop owner
and former narcotics officer whose store was raided during Operation
Log Jam. 196 Vandervert notes that the operation was unfettered mayhem
since DEA agents simply seized any and all products on site, thus attest-
ing that there is no immediate way to discriminate between legal or illegal
products. 197 Therefore, "there is a problem for everybody involved in the
synthetic drug crackdown: Cops don't know what they're looking at-
they have to send it to the DEA lab for testing-and retailers have to
make sure that what's inside their generically-branded bags is compli-
ant."198 Vandervert states that he rigorously ensured that all his products
abided with current laws or bans by periodically tracking legislation and
sending samples of his incense or bath salt products to be lab-analyzed
and checked for problematic ingredients. 199 Though the DEA has not yet
given him a clear answer as to whether or not his products were compli-
ant, Vandervert predicts that the DEA will simply respond with yet an-
other emergency ban, thus fueling the battle between law enforcement
agencies and synthetic drug manufacturers. 200
Opposition to broad bans has been voiced by members of Congress
and the scientific and medical communities, who fear that such sweeping
prohibitions will negatively impact scientific research and develop-
ment.201 Many of these substances may have medical value or therapeutic
benefits, yet their indiscriminate criminalization will suppress any oppor-
tunity of adequate scientific study.2 0 2 For example, MDMA (commonly
known as ecstasy), is currently a Schedule I drug, 203 yet studies have
shown that the drug has medical value in treating post-traumatic stress
disorder.204 Thus, rampant emergency regulations may have far-reaching
scientific and societal disadvantages: "'If you ban the whole class [of
193. See Beaudette, 97 So. 3d at 603-04.
194. See id. at 604.
195. See State v. Nickel, 806 N.W.2d 155, 158-59 (N.D. 2012).





201. See Knopf, supra note 8; see also Diaz, supra note 99.
202. See Knopf, supra note 8.
203. 21 U.S.C. § 812(c)(1) (2006) (listed as 3,4-methylenedioxy amphetamine).
204. See Knopf, supra note 8.
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drugs], you would be presuming no future benefits of any of these com-
pounds and that might be just as dangerous.' 2 0 5 This unfortunate truth
also raises concerns regarding the swift regulation and classification of
drugs into the Schedule I category, which requires that the drugs have
"no currently accepted medical use." 206 The fact that MDMA is a Sched-
ule I drug, yet was found to have medical benefits, at the very least raises
the possibility that newly banned analogues could likewise have medical
treatment benefits-a possibility that could go undiscovered without the
chance of independent scientific studies.207
Moreover, swift and sweeping Schedule I legislation like the SDAPA
presumes that the DEA has already adequately determined whether a
newly formulated compound has medical value because its criminaliza-
tion would likely halt any nongovernmental research or prolonged medi-
cal studies.208 Also, these potential issues could either be worsened or
alleviated by the fact that the SDAPA expands DEA authority by ena-
bling the DEA to issue longer emergency bans,209 which would allow the
DEA more time to study any threatening substances. 210 Conversely, it
would also further prolong the period of time during which independent,
commercial, or pharmaceutical scientific study of the banned substance
would be deemed a severe criminal offense.211 Notably, when DEA and
law enforcement agents expressed disappointment and disdain that the
SDAPA's probations were much too narrow, Senate Judiciary Chairman
Patrick Leahy (D-Vt) responded by warning the public of the foreboding
repercussions triggered by swift and widespread legislation.212 Although
he was politically accused of favoring the quick adoption of mild and lim-
ited prohibitions rather than taking the time to draft and enact more
drastic and all-encompassing legislation, a Senate supporter defended
Leahy's actions and pointed out very real societal consequences. 213
"'[Sicheduling controlled substances is not something to be taken
lightly.... It is not without implication to put a whole lot of chemicals on
the federal drug schedule . . . . It means putting more people in jail and
makes it harder to seek legitimate uses for these drugs." 214 These conse-
quences were not exclusively voiced by a few skeptics and designer drugs
supporters-but were echoed by physicians, scientists, and legislators
205. Id. (quoting H. Westley Clark, M.D.).
206. 21 U.S.C. § 812(b)(1)(B).
207. See Knopf, supra note 8.
208. Scheduler of Controlled Substances: Temporary Placement of Five Synthetic Can-
nabinoids Into Schedule I, 76 Fed. Reg. 11,075, 11,077 (Mar. 1, 2011) (codified at 21 C.F.R.
pt. 1308) (noting that the DEA reviewed available research for five cannabinoids and con-
cluded that they had no "accepted medical use" in the United States).
209. See Synthetic Drug Abuse Prevention Act of 2012, Pub. L. No. 112-144, § 1153,
126 Stat. 993, 1132.
210. See Abrams, supra note 100; see also Diaz, supra note 99.
211. See § 811(h)(2), 126 Stat. at 1132.






B. HISTORICAL PARALLELS AND FUTURE PERSPECTIVES
To forecast the success of constant bans and broad regulations, it is
useful to look at previous political attempts to eradicate designer drugs
and their rapidly emerging analogues. 216 For example, in examining the
regulatory schemes that were enacted to curtail the proliferation of
opiates in the 1920s and 1930s, one legal scholar notes that broad national
and international regulations have simply fueled supply, demand, and the
creativity of drug-traffickers, thus causing an increased opiate influx
within U.S. borders. 217 "From the outset of drug prohibition in the 1920s,
each act of suppression produced an equal and opposite criminal reac-
tion. .. . As soon as governments slashed imports or closed opium dens,
traffickers emerged to service the unmet demand." 218 This problem is al-
ready mirrored in today's war on synthetics, with the nation's newest de-
signer drug threats and chemical variations tracked to overseas suppliers
and underground laboratories located all over the world.219 Additionally,
the issue of designer drugs was already dealt with in the 1980s-an era of
emergent analogues that prompted the Controlled Substances Analogue
Enforcement Act of 1986220- and also produced significant case law
stressing the importance of careful judicial scrutiny in interpreting over-
broad designer drug legislation.221 Also, the NFHC label and the prolifer-
ation of analogues being mislabeled and sold under the guise of
household goods is a tactic that emerged as a direct consequence of the
Analogue Enforcement Act,2 2 2 which supports the argument that ram-
pant national legislation simply spawns new and equally troublesome sub-
stances, technologies, and regulatory issues.223 Moreover, the Internet
has added another layer of complexity to designer drug regulation by cre-
ating an e-market of buyers and sellers who can share ideas and foster the
importation and exportation of new synthetic ingredients. 224
In addition, the DEA and ICE have reported incidents of rogue manu-
facturers, with no scientific or chemical background, who have been
caught in local towns and neighborhoods, mixing and distributing their
own synthetic compounds from within their own homes.225 These recent
215. See id.; see also Diaz, supra note 99; Knopf, supra note 8.
216. Alfred W. McCoy, From Free Trade to Prohibition: A Critical History of the Mod-
ern Asian Opium Trade, 28 FORDHAM URB. L.J. 307, 327-28 (2000).
217. See id.
218. Id. at 328.
219. See WHITE HOUSE FACT SHEET, supra note 6.
220. See Duckworth, supra note 5 at 32.
221. United States v. Hodge, 321 F.3d 429, 437 (3d Cir. 2003); see United States v.
Forbes, 806 F. Supp. 232, 234-36 (D. Colo. 1992).
222. See Duckworth, supra note 5, at 32.
223. See McCoy, supra note 216, at 327-28.
224. See Rose, supra note 35 (noting the existence of YouTube video tutorials on how
to make synthetic marijuana).
225. See WHITE HOUSE FACr SHEET, supra note 6; see also News Release, ICE, 4 Fed-
erally Indicted in 'K2' Synthetic Drug Trafficking Conspiracy (May 18, 2012) [hereinafter
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drug-trafficking activities present U.S. courts with serious interstate and
international criminal issues such as "illegal importation, smuggling, dis-
tributing misbranded drugs and money laundering." 2 2 6 These problems
create doubts regarding the regulatory effectiveness of expending colos-
sal state and federal legislative and judicial efforts to procure the possible
convictions of a few convenience store owners 227 or uninformed consum-
ers.228 Though these defendants do pose public risks and are indeed by-
products of the designer drug industry, they are not exactly the main
source of the problem. Furthermore, head shops and convenience stores
are establishments that will likely thrive and exist with or without the
existence of synthetic drugs, mounting regulations, and DEA raids, since
these establishments sell many other nondrug-related products as well.2 2 9
Many question congressional motives and the efficacy of federal agencies
that have consistently failed to adapt and keep pace with synthetic drug
chemists and manufacturers.230 If widespread regulation proved ineffec-
tive in the 1920s and 1930s, 231 and again in the 1980s, 2 3 2 and also failed to
eradicate the sale and use of natural THC and well-established Schedule I
and Schedule II drugs, then such methods will likely prove ineffective for
the designer drugs of today, which pose the exact same national threats
and merely differ in chemical composition. Since the temporary bans did
not solve the synthetic drug problem, then implementing permanent bans
on the exact same substances are likely to have an underwhelming effect
against manufacturers and consumers. 233 Perhaps Congress and the DEA
should sharpen their regulatory tactics in light of historical parallels and
new international threats.234
Legislators and law enforcement officers should be cautious about their
broad, shotgun approach to prohibitions that could potentially render
synthetic drug possession an "overnight" felony and can cause mis-
informed consumers to incur dire criminal repercussions and incarcera-
tions of up to twenty years.235 Additionally, such uncoordinated and
expansive attempts can lead to the misuse of judicial resources by carry-
ing on lengthy trials and appeals to possibly convict misinformed consum-
ers and convenience store owners who may or may not be selling illegal
ICE News Release], available at http://www.ice.gov/news/releases/1205/120518portland.
htm.
226. See ICE News Release, supra note 225.
227. See Kelley, supra note 191.
228. See State v. Nickel, 806 N.W.2d 155, 159-60 (N.D. 2012).
229. See Federal Synthetic Drug Ban Filled With Future Loopholes, supra note 116; Kel-
ley, supra note 191 (noting that the manufacturing company who produced many of the
products confiscated in Operation Log Jam is still legally operating and open for business
in Tampa, Florida).
230. See Rose, supra note 35.
231. See McCoy, supra note 216, at 308.
232. See Duckworth, supra note 5, at 32.
233. See Smith, supra note 113 (noting that SDAPA legislation merely permanently
bans products that were already under a temporary ban).
234. See McCoy, supra note 216, at 308.
235. See State v. Nickel, 806 N.W.2d 155, 159-60 (N.D. 2011).
426 [Vol. 66
Synthetic Drugs
synthetics, depending on a variety of technical and time-sensitive de-
tails. 2 3 6 Synthetic drug convictions often require complex scientific deter-
minations and have outcomes that strongly hinge on external factors such
as the date and location of the offense, the chemical composition of the
substance, the wording of the prohibition, and the level of public knowl-
edge concerning the ban.2 3 7 Moreover, months of federal congressional
resources were needlessly consumed in the SDAPA's adoption-a super-
fluous regulation that had the underwhelming effect of merely scheduling
substances that were already being regulated under the temporary
bans. 2 3 8 Some skeptics even feel that the SDAPA was a regulatory disas-
ter-a carelessly drafted bill that was enacted without proper planning,
research, or foresight, simply to create political clout and serve as a public
manifestation that Congress did indeed do something to fix the
problem. 239
Designer drugs present a multifaceted problem that is not likely to be
wiped out by any one piece of legislation.240 Thus, state and federal law
enforcement agencies should deviate from the endless and legally danger-
ous cycle of legislation and ban implementation, 241 and focus on specifi-
cally targeting the source-those local and international chemists,
laboratories, and manufacturers who create and mislabel dangerous prod-
ucts. In confronting the spread of synthetic drugs, state and federal gov-
ernments have collaborated on proposing bills, drafting legislation, and
even conducting national raids.242 Yet such overarching joint efforts may
have overshadowed the efficiency of allowing individual state legislative
and judiciary branches to regulate in a more localized manner,243 which
would let the federal government tackle larger threats such as overseas
importation, synthetic drug laboratories, and illegal sales via the In-
ternet.244 Likewise, federal governmental agencies such as the DEA,
ICE, U.S. Customs and Border Patrol, and the FBI should focus on col-
laborating with one another to control these threats, rather than involving
state and local police forces to conduct head shop raids2 4 5 or exhausting
resources lobbying for inefficient national legislation.246 For example, in
236. See id. at 156, 160 (noting that the State appealed three prior orders dismissing
synthetic drug charges against Nickel, only to have the dismissal affirmed by the North
Dakota Supreme Court); see also Kelley, supra note 127.
237. See Haag v. State, 823 N.W.2d 749, 750-51 (N.D. 2012) (noting the court's analysis
became a timing question to determine whether the substance was illegal on the date of the
offense); Nickel, 806 N.W.2d at 158-60.
238. See Smith, supra note 113.
239. See id.
240. See Keim, supra note 117; Rose, supra note 35.
241. See Goldman, supra note 119.
242. See DEA News Release 1 supra note 9; Smith, supra note 113.
243. See Phillip Smith, Rand Paul Blocks Federal Synthetic Drug Bans, STOPTHEDRUG
WAR.ORG (Feb. 20, 2012, 5:09 P.M.), http://stopthedrugwar.org/chronicle/2012/feb/20/rand
paul blocksjfederal-synthet (noting that Senator Rand Paul believes that "'enforcement
of most drug laws can and should be local and state issues"').
244. See WHiE HOUSE FACT SHEET, supra note 6.
245. DEA News Release 1, supra note 9.
246. See Keim, supra note 117.
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State v. Brotherton, New York Attorney General Eric Schneiderman suc-
cessfully won a battle against a local head shop under the state's false
labeling statute,247 and also filed suits against sixteen other stores.248 Cur-
rently, forty-five states have enacted their own bans on specific ana-
logues, 249 and state judicial systems have shown that they are capable of
addressing synthetic drug cases and enforcing civil remedies and criminal
penalties for state and federal violations. 250 One possible solution to ef-
fectively combat synthetics is to operate outside of the repetitive tactic of
constant DEA bans and national legislation, which can drain local and
national resources. 251 Rather, Congress should encourage a regulatory di-
chotomy wherein the states can police localized issues regarding posses-
sion, distribution, and retail of illegal substances, while federal agencies
combine their skills and resources to eradicate and circumvent larger na-
tional threats such as underground laboratories and synthetic drug
manufacturers.252
V. CONCLUSION
The emergence of synthetic drugs in the United States has created so-
cial, political, and legal complexities that do not have a simple or definite
solution. Since these substances are easily synthesized and are in a con-
stant state of metamorphosis, they have created grey areas in a political
system that operates under black and white law. In response, Congress
and the DEA have tried to swiftly enact all-encompassing legislation to
thwart a multifaceted problem-a response that has created its own set of
legal repercussions. Despite those who doubt the efficiency of swift
scheduling and across-the-board regulation, recent reports actually show
that the number of reported bath salt cases has been on the decline as of
late 2012-a fact that is perhaps attributable to either gruesome and cau-
tionary media coverage, recent legislation, or both; however, these
sources have made no mention of the decline of Spice or synthetic mari-
juana cases. 253
Furthermore, there are still reports of law enforcement agents simply
encountering new and unknown synthetics, which remain problematically
247. See State v. Brotherton, No. 12-0969 (N.Y. Sup. Ct. Oct. 23, 2012), http://www.ag.
ny.gov/press-release/ag-scheiderman-wins-court-victory-push-ban-mislabeled-drugs-head-
shops (follow "click here to read the decision in full" hyperlink) (order granting permanent
injunction).
248. Schneiderman Press Release, supra note 128.
249. Synthetic Drug Threats, NATIONAL CONFERENCE OF STATE LEGISLATURES, Nov.
28, 2012, http://www.ncsl.org/issues-research/justice/synthetic-drug-threats.aspx.
250. See Haag v. State, 823 N.W.2d 749, 752-53 (N.D. 2012).
251. See Kelley, supra note 127 (predicting that many Operation Log Jam charges will
be dismissed).
252. See Synthetic 'Bath Salts' An Evolving Problem for DEA, supra note 73; see also
ICE News Release, supra note 225.
253. See Vimont, supra note 44. But see Denise G. Callahan, Cases Involving 'Bath Salt'




legal and unregulated.254 It may be too early to predict whether
America's synthetic drug problem will merely be a short-lived epidemic
that will eventually be weeded out by rigorous regulations or whether it
will be an ongoing issue. But history and science have shown that drugs-
whether natural or synthetic-have always posed complex issues for state
and federal regulators, the legal community, and the public at large.255 At
present, designer drugs certainly pose a palpable danger, especially to cu-
rious and uninformed youths.256 Although rampant legislation might
seemingly be a quick fix, Congress and federal agencies should realize
that it is an overused strategy that has been historically ineffective 257 and
presents its own set of social and legal pitfalls. 258 Ultimately, legislators
and the courts must aim to adapt to the reality of synthetics and grapple
with an industry that poses both a slippery slope and a fine line between
the legally permissible and drastically criminal.
254. See Keim, supra note 117.
255. See McCoy, supra note 216, at 307-08, 327-28; Keim, supra note 117.
256. See WHITE HOUSE FAcr SHEET, supra note 6.
257. See McCoy, supra note 216, at 308 (noting that the U.S. Government "anticipates a
simple, direct connection between repression and results").
258. See Goldman, supra note 119; see also Knopf, supra note 8.
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